摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-cyclopropyl-8-[2-(4-difluoromethoxy-3-fluoro-phenyl)-ethyl]-5,6-dihydro-8H-imidazo[1,5-a]pyrazine-7-carboxylic acid tert-butyl ester | 1202691-23-3

中文名称
——
中文别名
——
英文名称
3-cyclopropyl-8-[2-(4-difluoromethoxy-3-fluoro-phenyl)-ethyl]-5,6-dihydro-8H-imidazo[1,5-a]pyrazine-7-carboxylic acid tert-butyl ester
英文别名
tert-butyl 3-cyclopropyl-8-[2-[4-(difluoromethoxy)-3-fluorophenyl]ethyl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxylate
3-cyclopropyl-8-[2-(4-difluoromethoxy-3-fluoro-phenyl)-ethyl]-5,6-dihydro-8H-imidazo[1,5-a]pyrazine-7-carboxylic acid tert-butyl ester化学式
CAS
1202691-23-3
化学式
C23H28F3N3O3
mdl
——
分子量
451.489
InChiKey
QPFPXLRNVYBVIA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    32
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    56.6
  • 氢给体数:
    0
  • 氢受体数:
    7

文献信息

  • 5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE COMPOUNDS
    申请人:Aissaoui Hamed
    公开号:US20110105514A1
    公开(公告)日:2011-05-05
    The invention relates to 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives of formula (I) wherein R 1 , R 2 , R 3 , and R 4 are as described n the description, to salts, especially pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments; especially as orexin receptor antagonists.
    这项发明涉及式(I)的5,6,7,8-四氢咪唑[1,5-a]吡嗪生物,其中R1、R2、R3和R4如描述中所述,以及其盐,特别是药用可接受的盐,以及将这类化合物用作药物的用途;特别是作为促进睡眠的受体拮抗剂。
  • [EN] 5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE COMPOUNDS<br/>[FR] COMPOSÉS DE 5,6,7,8-TÉTRAHYDRO-IMIDAZO[1,5-A]PYRAZINE
    申请人:ACTELION PHARMACEUTICALS LTD
    公开号:WO2009156951A2
    公开(公告)日:2009-12-30
    The invention relates to 5,6,7,8-tetrahydro-imidazo[1,5- a]pyrazine derivatives of formula (I) wherein R1, R2, R3, and R4 are as described n the description, to salts, especially pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments; especially as orexin receptor antagonists.
查看更多